Abstract
This study was undertaken to determine the value of Doppler ultrasonography in the early evaluation of therapeutic efficacy of hepatocellular carcinoma after transcatheter arterial embolization (TAE). Fifty-two nodules in which tumor vascularity had been detected by Doppler ultrasonography before TAE were examined in 41 patients. Doppler signals were evaluated 1 week after TAE, and the results were compared with tumor vascularity as determined by dynamic magnetic resonance imaging (dynamic MRI), which was used as the gold standard. The sonographic signal disappeared in 41 (79%) of the 52 nodules and remained in 11 (21%). All nodules in which intratumor vascularity had been detected showed positive stain to dynamic MRI. Four of 41 nodules in which the sonographic signal disappeard showed positive stain on dynamic MRI. The Sensitivity of Doppler ultrasonography was 73%; specificity, 100%; and accuracy, 92%. Flow signal in deeply (≥5 cm) located small (<3 cm) nodules tended to be more difficult to detect. We conclude that Doppler ultrasonography warrants use after TAE in the early evaluation as a specific and noninvasive imaging technique.
Similar content being viewed by others
References
Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma.Radiology 1983;148: 397–401.
Takayasu K, Wakao F, Furukawa H: Lipiodol-TAE Theraphy for hepatocellular carcinoma: Assessment of efficacy by dynamic computed tomography. Diag Imag Abd 1993;13; 738–743. [in Japanese]
Nishimine K, Uchida H, Matsuo N, et al: Segmental transaterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: Follow-up CT and therapeutic results.Cancer Chemother Pharmacol 1994;33: 60–68.
Kojiro M, Nakashima T: Pathological aspects on TAE therapy. Journal of Clinical Surgery 1984;39: 979–985. [in Japanese]
Hirohashi K, Sakai K, kinoshita H, et al: Hepatectomy after transcatheter arterial embolization (TAE) for hepatocellular carcinomas. Journal of Japan Surgical Society 1985;86: 555–565. [in Japanese]
Wakasa K, Sakurai M, Kuroda C, et al: Effect of transcatheter arterial embolization on the boundary architecture of hepatocellular carcinoma.Cancer 1990;65: 913–919.
Gabata T, Matsui O, Kadoya M, et al: MR evaluation of necrosis of hepatocellular carcinoma treated by TAE. 1993;13: 744–752. [in Japanese]
Yamashita Y, Yoshimatsu S, Sumi M, et al: Dynamic MR imaging of hepatoma treated by transcatheter arterial embolization theraphy assessment of treatment effect.Acta Radiologica 1993;34: 303–308.
Ito K, Choji T, Nakada T, et al: Multiple dynamic MRI of hepatic tumors.J Comput Assist Tomogr 1993;17: 390–396.
Kuwata Y, Hirota S, Sugimoto K, et al.: Clinical evaluation of dynamic MRI in the re-diagnosis of therapeutic effect and recurrence after transcatheter arterial-embolization for hepatocellular carcinoma. Jpn J Cancer Chemother 1994;21: 1235–1240. [in Japanese]
Yamakawa K, Ito S, Fukatsu H, et al: Evaluation of the effect of transcatheter arterial embolization treatment on hepatocellular carcinoma using dynamic MRI. Jpn J Tomgr 1994;20: 174–178. [in Japanese]
Ito K, Honjo K, Fujita T, et al: Therapeutic efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology.J Comput Assist Tomogr 1995;19: 198–203.
Hirohashi S, Hirohashi R, Uchida H, et al: MR imaging for the treatment of the liver cancer. Diag Imag Abd 1995;15: 111–120. [in Japanese]
Murakami T, Nakamura H, Tsuda K, et al: Hepatic mass lesion needs to be differentiated from hepatocellular carcinoma-MR imaging including the changes after treatment of the TAE or PEIT. Diag Imag Abd 1995;15: 790–798 [in Japanese]
Tanaka S, Kitamura T, Fujita M, et al: Color Doppler flow imaging of liver tumors. AJR 1990;154: 509–514.
Tanaka K, Okazaki H, Nakamura S, et al: Color Doppler sonographic features of hepatocellular carcinoma and the evaluation of the effect of transcatheter arterial embolization. J Med Ultrasonics 1991;18: 429–435. [in Japanese]
Tanaka K, Inoue S, Numata K, et al: Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization.AJR 1992;158: 541–546.
Kudo M, Tomita S, Hirasa M, et al: Evaluation of therapeutic effect of TAE for hepatocellular carcinoma; assesment with ultrasonography and color Doppler imaging. Diag Imag Abd 1993;13: 724–737. [in Japanese]
Rubin JM, Bude RO, Carson PL, et al: Power Dopple US: a potentially useful altenative to mean frequency based color Doppler US.Radiology 1994;190: 853–856.
Ohishi H, Hirai T, Yamada R, et al: Clinical evaluation of power Doppler sonography for the diagnosis of hepatocellular carcinoma. Nippon Acta Radiologica 1996;56: 399–404. [in Japanese]
Tochio H, Kashida H, Tomita S, et al: Power Doppler houno rinsyououyou-kansyuryu no ketsuryudoutai kara mita shitsutekishindan-.J Adult Dis 1997;27: 1075–1082. [in Japanese]
Kudo M, Tochio H: Ultrasonography-diagnosis of early HCC and borderline lesions.Japanese Journal of Diagnostic Imaging 1997;17: 1044–1050. [in Japanese]
Kim DE Kim RN, Lee HJ, et al: Vasculature in hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of power and color Doppler sonography.J Ultrasound Med 1998;17: 9–15.
Kudo M: Progress of imaging diagnosis of hepatocellular carchinoma. J Adult Dis 1998;28: 800–810. [in Japanese]
Yutoku H, Kurokawa N, Ymasaki T, et al: Power Doppler wo mochiita syoukansaibougan no keturyubyousyutsunou to chiryoukoukahantei ni kansuru kentou. 32th Annual Meeting of Liver Cancer Study Group 1996. [in Japanese]
Ryu M, Shimamura Y, Kinoshita T, et al: Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: A retrospective multicenter study. Jp J Clinical Oncol 1997;8: 251–257. [in Japanese]
Author information
Authors and Affiliations
About this article
Cite this article
Hibi, T., Kumada, T., Takeshima, K. et al. Clinical utility of doppler ultrasonography in evaluation of early therapeutic efficacy after transcatheter arterial embolization in patients with hepatocellular carcinoma. J Med Ultrasonics 29, 47–53 (2002). https://doi.org/10.1007/BF02481439
Issue Date:
DOI: https://doi.org/10.1007/BF02481439